Cargando…

Protective Effect of Recombinant Human Leukemia Inhibitory Factor against Thrombocytopenia in Carboplatin‐treated Mice

The protective effect of recombinant human leukemia inhibitory factor (rhLIF) against development of throrabocytopenia in carboplatin (CBDCA; cis‐diammine‐l, l‐cyclobutane dicarboxylate platinum II)‐treated mice was examined. The optimal dose of rhLIF was determined by administering doses of rhLIF r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akiyama, Yasuto, Kikuchi, Yasufumi, Matsuzaki, Junichi, Kajimura, Naoko, Ohue, Chiharu, Yamaguchi, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1997
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921474/ https://www.ncbi.nlm.nih.gov/pubmed/9263536 http://dx.doi.org/10.1111/j.1349-7006.1997.tb00422.x

Ejemplares similares

In vivoEffect of Recombinant Human Leukemia Inhibitory Factor in Primates
por: Akiyama, Yasuto, et al.
Publicado: (1997)

Cytokine Production in Five Tumor Cell Lines with Activity to Induce Cancer Cachexia Syndrome in Nude Mice
por: Iseki, Hideaki, et al.
Publicado: (1995)

Carboplatin/etoposide: Neutropenia and thrombocytopenia: case report
Publicado: (2021)

Tumor Necrosis Factor‐a Stimulates Colony Formation by a Megakaryoblastic Leukemia Cell Line, CMK
por: Akiyama, Yasuto, et al.
Publicado: (1992)

Recombinant purified buffalo leukemia inhibitory factor plays an inhibitory role in cell growth
por: Ali, Syed Azmal, et al.
Publicado: (2018)

Protein-protein Interaction Network Prediction by Using Rigid-Body Docking Tools: Application to Bacterial Chemotaxis
por: Matsuzaki, Yuri, et al.
Publicado: (2014)

Specificity of broad protein interaction surfaces for proteins with multiple binding partners
por: Uchikoga, Nobuyuki, et al.
Publicado: (2016)

The Inhibitory Effect of Carboplatin Injection on Human Neuroblastoma SK-N-SH
por: Xu, Jianfeng, et al.
Publicado: (2020)

Highly precise protein-protein interaction prediction based on consensus between template-based and de novo docking methods
por: Ohue, Masahito, et al.
Publicado: (2013)

Re-Docking Scheme for Generating Near-Native Protein Complexes by Assembling Residue Interaction Fingerprints
por: Uchikoga, Nobuyuki, et al.
Publicado: (2013)

MEGADOCK: An All-to-All Protein-Protein Interaction Prediction System Using Tertiary Structure Data
por: Ohue, Masahito, et al.
Publicado: (2014)

MEGADOCK-Web: an integrated database of high-throughput structure-based protein-protein interaction predictions
por: Hayashi, Takanori, et al.
Publicado: (2018)

Inhibitory effect of carboplatin in combination with bevacizumab on human retinoblastoma in an in vitro and in vivo model
por: Zhang, Qi, et al.
Publicado: (2017)

Carboplatin-Induced Thrombocytopenia through JAK2 Downregulation, S-Phase Cell Cycle Arrest and Apoptosis in Megakaryocytes
por: Wu, Yi-Hong, et al.
Publicado: (2022)

MEGADOCK 4.0: an ultra–high-performance protein–protein docking software for heterogeneous supercomputers
por: Ohue, Masahito, et al.
Publicado: (2014)

Production of biologically active recombinant buffalo leukemia inhibitory factor (BuLIF) in Escherichia Coli
por: Jamwal, Shradha, et al.
Publicado: (2022)

MEGADOCK 3.0: a high-performance protein-protein interaction prediction software using hybrid parallel computing for petascale supercomputing environments
por: Matsuzaki, Yuri, et al.
Publicado: (2013)

Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia
por: Ookura, Miyuki, et al.
Publicado: (2018)

Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection
por: Foronjy, Robert F, et al.
Publicado: (2014)

How nephrotoxic is carboplatin?
por: Hardy, J. R., et al.
Publicado: (1990)

Carboplatin binding to histidine
por: Tanley, Simon W. M., et al.
Publicado: (2014)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents
por: Miklosz, Joanna, et al.
Publicado: (2019)

Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma
por: Dechaphunkul, Tanadech, et al.
Publicado: (2011)

Endogenous leukemia inhibitory factor protects photoreceptor cells against light-induced degeneration
por: Bürgi, Sandra, et al.
Publicado: (2009)

Association between Area under the Curve Estimated from Carboplatin Dose and Incidence of Severe Thrombocytopenia in Patients with Non-Hodgkin’s Lymphoma on DeVIC Therapy
por: Umehara, Kengo, et al.
Publicado: (2023)

Carboplatin and renal function in children.
por: Stevens, M. C., et al.
Publicado: (1991)

Haematological toxicity of carboplatin in rats.
por: Siddik, Z. H., et al.
Publicado: (1987)

Carboplatin-Induced Hypersensitivity Reaction
por: Potolidis, Evangelos, et al.
Publicado: (2012)

Hypersensitivity to Carboplatin in Children with Malignancy
por: Ruggiero, Antonio, et al.
Publicado: (2017)

Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy
por: Koshiyama, Masafumi, et al.
Publicado: (2017)

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.
por: Rankin, E. M., et al.
Publicado: (1992)

Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?
por: Ayhan, Sevgi, et al.
Publicado: (2023)

Improvement of pregnancy rate by intrauterine administration of dexamethasone and recombinant human leukemia inhibitory factor at the time of embryo transfer in cattle
por: Roh, Sangho, et al.
Publicado: (2016)

Leukemia Inhibitory Factor Protects Axons in Experimental Autoimmune Encephalomyelitis via an Oligodendrocyte-Independent Mechanism
por: Gresle, Melissa M., et al.
Publicado: (2012)

Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice
por: Yang, Xiu-Fen, et al.
Publicado: (2018)

Protective effect of leukemia inhibitory factor on the retinal injury induced by acute ocular hypertension in rats
por: Lv, Jiexuan, et al.
Publicado: (2022)

Polarized secretion of Leukemia Inhibitory Factor
por: Hill, Eric J, et al.
Publicado: (2008)

NRLMFβ: Beta-distribution-rescored neighborhood regularized logistic matrix factorization for improving the performance of drug–target interaction prediction
por: Ban, Tomohiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_quetn7qmaitvg6ekb5nrlk9q11